Palliative Care in High-Grade Glioma: A Review

por Crooms, Rita C., Goldstein, Nathan E., Diamond, Eli L., Vickrey, Barbara G.
Publicado 2020

A Population-Based Study of Treatment and Survival in Older Glioma Patients

por Reiner, Anne S, Lobaugh, Stephanie M, Gonen, Selin, Diamond, Eli L, Panageas, Katherine S
Publicado 2022

Giant cell arteritis presenting with bilateral orbital inflammatory disease and enhancing superficial temporal arteries

por Mitchell, Jamie R, Krashin-Bichler, Iris, Rosenblum, Marc, Diamond, Eli L, Dinkin, Marc J
Publicado 2014

Erdheim-Chester disease among neuroinflammatory syndromes: the case for precision medicine

por de la Fuente, Macarena I., Rosenblum, Marc K., Diamond, Eli L., Tabar, Viviane S., Omuro, Antonio
Publicado 2020

Rosai–Dorfman–Destombes disease of the nervous system: a systematic literature review

por Nasany, Ruham Alshiekh, Reiner, Anne S., Francis, Jasmine H., Abla, Oussama, Panageas, Katherine S., Diamond, Eli L.
Publicado 2022

Necrotizing myositis in a rectus muscle arising in the setting of long-standing Langerhans cell histiocystosis and recent dabrafenib treatment

por van Landingham, Suzanne W., Puccetti, Diane, Potter, Heather, Gamm, David, Diamond, Eli L., Lucarelli, Mark J.
Publicado 2020

Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study

por Goldman, Debra A, Reiner, Anne S, Diamond, Eli L, DeAngelis, Lisa M, Tabar, Viviane, Panageas, Katherine S
Publicado 2020

Cobimetinib‐induced “dropped head syndrome” and subsequent disease management in an Erdheim‐Chester patient

por King, Amber C., Diamond, Eli L., Orozco, Jennifer S., Morse, Hannah R., Ouyang, Linda L., Schöder, Heiko, Rampal, Raajit K.
Publicado 2019

Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease

por Diamond, Eli L., Hatzoglou, Vaios, Patel, Sneha, Abdel-Wahab, Omar, Rampal, Raajit, Hyman, David M., Holodny, Andrei I., Raj, Ashish
Publicado 2016

(18)F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study

por Kirchner, Julian, Hatzoglou, Vaios, Buthorn, Justin B., Bossert, Dana, Sigler, Allison M., Reiner, Anne S., Ulaner, Gary A., Diamond, Eli L.
Publicado 2020

Histiocytosis and the nervous system: from diagnosis to targeted therapies

por Cohen Aubart, Fleur, Idbaih, Ahmed, Emile, Jean-François, Amoura, Zahir, Abdel-Wahab, Omar, Durham, Benjamin H, Haroche, Julien, Diamond, Eli L
Publicado 2021

Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim–Chester disease patients following BRAF inhibitor monotherapy

por Mazor, Roei D, Weissman, Ran, Luckman, Judith, Domachevsky, Liran, Diamond, Eli L, Abdel-Wahab, Omar, Shapira, Shirley, Hershkovitz-Rokah, Oshrat, Groshar, David, Shpilberg, Ofer
Publicado 2020

CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition

por Diamond, Eli L., Francis, Jasmine H., Lacouture, Mario E., Rotemberg, Veronica, Yabe, Mariko, Petrova-Drus, Kseniya, Ulaner, Gary A., Reddy, Ryan, Abdel-Wahab, Omar, Durham, Benjamin H.
Publicado 2023

Erdheim–Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib

por Riancho, José A., Hernández, José L., González-Vela, Carmen, López-Sundh, Ana E., González-Lopez, Marcos A., Gomez de la Fuente, Francisco, Quirce, Remedios, Diamond, Eli L.
Publicado 2023

Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis

por Aaroe, Ashley, Kurzrock, Razelle, Goyal, Gaurav, Goodman, Aaron M., Patel, Harsh, Ruan, Gordon, Ulaner, Gary, Young, Jason, Li, Ziyi, Dustin, Derek, Go, Ronald S., Diamond, Eli L., Janku, Filip
Publicado 2023

Intra-arterial Melphalan for Neurologic Non-Langerhans Cell Histiocytosis

por Francis, Jasmine H., Gobin, Y. Pierre, Nasany, Ruham Alshiekh, Knopman, Jared, Ulaner, Gary A., Panageas, Katherine S., Hatzoglou, Vaios, Salvaggio, Kim, Abramson, David H., Patsalides, Athos, Diamond, Eli L.
Publicado 2021

Challenges and positive impact of rare cancer caregiving: A mixed-methods study of caregivers of patients with Erdheim-Chester disease and other histiocytic neoplasms

por Mitchell, Hannah-Rose, Applebaum, Allison J., Lynch, Kathleen A., Reiner, Anne S., Atkinson, Thomas M., Buthorn, Justin J., Sigler, Allison S., Bossert, Dana, Brewer, Kathleen, Corkran, Jessica, Fournier, Deanna, Panageas, Katherine S., Diamond, Eli L.
Publicado 2022

Dyadic communication in rare cancer: a registry-based study of patients with Erdheim-Chester disease and their caregivers

por Reiner, Anne S., Applebaum, Allison J., Bossert, Dana, Buthorn, Justin J., Sigler, Allison M., Fournier, Deanna, Brewer, Kathleen, Atkinson, Thomas M., Lynch, Kathleen A., Gilliland, Jaime, Mao, Jun J., Panageas, Katherine S., Diamond, Eli L.
Publicado 2023

MicroRNA-15a-5p acts as a tumor suppressor in histiocytosis by mediating CXCL10-ERK-LIN28a-let-7 axis

por Weissman, Ran, Diamond, Eli L., Haroche, Julien, Durham, Benjamin H., Cohen, Fleur, Buthorn, Justin, Amoura, Zahir, Emile, Jean-François, Mazor, Roei D., Shomron, Noam, Abdel-Wahab, Omar I., Shpilberg, Ofer, Hershkovitz-Rokah, Oshrat
Publicado 2021

Patient-reported fatigue and pain in Erdheim-Chester disease: a registry-based, mixed methods study

por Reiner, Anne S., Bossert, Dana, Buthorn, Justin J., Sigler, Allison M., Gonen, Selin, Fournier, Deanna, Brewer, Kathleen, Corkran, Jessica, Goyal, Gaurav, Allen, Carl E., McClain, Kenneth L., Atkinson, Thomas M., Lynch, Kathleen A., Mao, Jun J., Panageas, Katherine S., Diamond, Eli L.
Publicado 2022